Fatty Liver in Long Standing Cholecystectomy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Post-cholecystectomy Metabolic Changes -Hepatic Steatosis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patiens
Overview
This observational study aims to evaluate the association between long-term cholecystectomy and the development of metabolic dysfunction-associated fatty liver disease (MAFLD) in adult patients. The study will assess the prevalence and severity of hepatic steatosis in individuals who underwent cholecystectomy several years earlier and compare clinical, metabolic, and biochemical parameters to identify potential risk factors. The goal is to determine whether cholecystectomy contributes to metabolic alterations that increase the likelihood of MAFLD in the long term.
Primary outcome measures
- Incidence and severity of metabolic dysfunction-associated fatty liver disease (MAFLD) in patients after long term follow up post cholecystectomy [Time frame: 5 years post-cholecystectomy]
Secondary outcome measures (1)
- Changes in serum level of ALT in post-cholecystectomy patients [Time frame: Annually for 5 years]
Eligibility criteria
Inclusion criteria
\-
Exclusion criteria
- Patients less than 18 years old.
- Body mass index (BMI) ≤ 25 kg/m2
- Patients with chronic renal failure.
- Patients with liver cirrhosis.
- Patients with acute liver dysfunction.
- Breast feeding and pregnancy.
- patients have done cholecystectomy less than 5 years ago.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07284004 · Soh-Med--25-11-6MS